These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. New approaches for in silico identification of cytokine-modified beta cell gene networks. Kutlu B, Naamane N, Berthou L, Eizirik DL. Ann N Y Acad Sci; 2004 Dec; 1037():41-58. PubMed ID: 15699492 [Abstract] [Full Text] [Related]
11. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy. Iwahashi H, Itoh N, Yamagata K, Imagawa A, Nakajima H, Tomita K, Moriwaki M, Waguri M, Yamamoto K, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y. Cytokines Cell Mol Ther; 1998 Mar; 4(1):45-51. PubMed ID: 9557216 [Abstract] [Full Text] [Related]
14. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y. Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417 [Abstract] [Full Text] [Related]
16. IFN-gamma sensitizes MIN6N8 insulinoma cells to TNF-alpha-induced apoptosis by inhibiting NF-kappaB-mediated XIAP upregulation. Kim HS, Kim S, Lee MS. Biochem Biophys Res Commun; 2005 Oct 28; 336(3):847-53. PubMed ID: 16154537 [Abstract] [Full Text] [Related]
17. Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning. Hägerkvist R, Sandler S, Mokhtari D, Welsh N. FASEB J; 2007 Feb 28; 21(2):618-28. PubMed ID: 17135364 [Abstract] [Full Text] [Related]
18. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus. Lin B, Zhang ZL, Yu LY, Guo LH. Acta Pharmacol Sin; 2003 Dec 28; 24(12):1199-204. PubMed ID: 14653944 [Abstract] [Full Text] [Related]